Open AccessLymphocyte to monocyte ratio-based nomogram for predicting outcomes of hepatocellular carcinoma treated with sorafenib
Author(s) -
Yeonjung Ha,
Mohamed A. Mohamed Ali,
M. Petersen,
William S. Harmsen,
Terry M. Therneau,
Han Chu Lee,
Baek Yeol Ryoo,
Sally Afua Bampoh,
Kenneth Valles,
Mohamad Mady,
Venkata Missula,
Kritika Prasai,
Lewis R. Roberts,
Kang Mo Kim
Publication year - 2020
Publication title -
hepatology international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.304
H-Index - 45
eISSN - 1936-0541
pISSN - 1936-0533
DOI - 10.1007/s12072-020-10076-4
Subject(s) - medicine , sorafenib , hepatocellular carcinoma , hazard ratio , nomogram , proportional hazards model , cohort , gastroenterology , confidence interval , oncology
The ability of the pretreatment lymphocyte to monocyte ratio (LMR) to predict outcomes of patients with hepatocellular carcinoma (HCC) receiving sorafenib is not conclusively determined.